Lobbying Information
Subject Matters
- Consumer Issues
- Health
- Industry
- Intellectual Property
- International Trade
- Regional Development
- Science and Technology
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Food and Drugs Act, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
- Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
- Schedules to the Patent Act related to Canada's Access to Medicines Regime, specifically, Schedules 1, 2, 3 and 4
Legislative Proposal, Bill or Resolution, Policies or Program
- Canada's Food and Consumer Safety Action Plan, specifically proposed legislation and regulation with repect to therapeutic products
Policies or Program
- Canada's strategic objectives and initiatives related to the Global Fund to Fight AIDS, Tuberculosis and Malaria
- Food and Drugs Act administration, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
- Health Canada and Public Health Agency of Canada policies and programs to eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy
- Health Canada's office of pharmaceutical management strategies, particularly as it relates to Health Canada's role in supporting and directing federal, national and inter-jurisdictional pharmaceutical policy
- Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
- Input on the work of the Advisory Committee on the Implementation of National Pharmacare, specifically as it relates to the evaluation and funding of medicines
Policies or Program, Regulation
- Regulations, guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
Regulation
- Food and Drugs Act Regulations with respect to Data Protection under C.08.004.
- Food and Drugs Act Regulations, specifically with respect to the authorization, regulation and life-cycle management of therapeutic products
- Health Canada Legislative and Regulatory Modernization initiatives as related to the regulation and life-cycle management of therapeutic products
- Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations and the administration of those regulations by Health Canada and Industry Canada
- Regulations Amending the Food and Drug Regulations (FDR) (1402 - Drugs for Developing Countries) related to Canada's Access to Medicines Regime
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Privy Council Office (PCO)
-
Treasury Board Of Canada Secretariat (TBS)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
333 LAKESIDE DRIVE
FOSTER CITY, CA 94404
United States of America
Telephone number:
650-574-3000
Client representative
BRANDON BOSS, Associate General Counsel
Parent Company Information
GILEAD SCIENCES, INC. is not a subsidiary of any other parent companies.
Coalition Members Information
GILEAD SCIENCES, INC. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of GILEAD SCIENCES, INC. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
- GILEAD SCIENCES CANADA, INC.
-
6711 MISSISSAUGA ROAD
SUITE 202
MISSISSAUGA, ON L5N 2W3
Canada
Lobbyist Details
WILLIAM DEMPSTER
|
Public offices held
Business address:
150 Metcalfe Street
Suite 604
OTTAWA, ON K2P 1P1
Canada
Telephone number:
613-614-0283
Fax number:
613-249-3645
Consultant Firm and Address
Firm:
3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.
Address:
150 Metcalfe Street
Suite 604
Ottawa, ON K2P 1P1
Canada
Telephone number:
613-800-8340
Fax number:
613-800-8343
